
Trial Shows Tirzepatide May Benefit People with Obesity, Kidney Disease and Heart Failure
The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, according to study published in Journal of the American …